NEOADJUVANT MELANOMA

Clinical trials for NEOADJUVANT MELANOMA explained in plain language.

Never miss a new study

Get alerted when new NEOADJUVANT MELANOMA trials appear

Sign up with your email to follow new studies for NEOADJUVANT MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Experimental cancer drug trial halted early

Disease control Terminated

This study tested an experimental drug called TransCon TLR7/8 Agonist, given as an injection into tumors, either alone or with another drug (pembrolizumab). It aimed to find a safe dose and check for side effects in people with advanced solid tumors that had stopped responding to…

Matched conditions: NEOADJUVANT MELANOMA

Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control

Last updated May 12, 2026 13:43 UTC

NEOADJUVANT MELANOMA

Get alerted when new NEOADJUVANT MELANOMA trials appear

Experimental cancer drug trial halted early